文章摘要
Yun Shi,Yang Shi,Xuli Yang,Jianrong Chen,Qi Qian,Dengfu Yao,Guangzhou Wu. Abnormal expression of VEGF and its gene transcription status as diagnostic indicators in patients with non-small cell lung cancer. Oncol Transl Med, 2015, 1: 201-207.
肺癌患者VEGF表达与基因转录的诊断价值
Abnormal expression of VEGF and its gene transcription status as diagnostic indicators in patients with non-small cell lung cancer
Received:March 11, 2015  Revised:October 05, 2015
DOI:10.1007/s10330-015-0077-9
中文关键词: 肺癌;VEGF表达;基因转录;诊断价值
英文关键词: lung cancer; vascular endothelial growth factor (VEGF); VEGF mRNA; reverse transcriptionpolymerase chain reaction (RT-PCR); immunohistochemistry
基金项目:Supported in part by a grant from the Project of Health Department of Jiangsu Province, China (No. H201454).
Author NameAffiliationE-mail
Yun Shi Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China yaodf@ahnmc.com 
Yang Shi Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China yaodf@ahnmc.com 
Xuli Yang Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China yaodf@ahnmc.com 
Jianrong Chen Department of Respiration Medicine, The 1st People's Hospital of Nantong City, Nantong 226001, China yaodf@ahnmc.com 
Qi Qian Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China yaodf@ahnmc.com 
Dengfu Yao* Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, China yaodf@ahnmc.com 
Guangzhou Wu Department of Cardiothoracic Surgery, The Affiliated Yancheng Hospital of Nantong University, Yancheng 224301, China yaodf@ahnmc.com 
Hits: 8363
Download times: 11185
中文摘要:
  分析了肺癌患者VEGF表达与基因转录的诊断价值
英文摘要:
    Objective: Angiogenesis is known to be essential for the survival, growth, invasion, and metastasis of lung cancer cells. Vascular endothelial growth factor (VEGF) is an important factor regulating angiogenesis of non-small cell lung cancer (NSCLC); however, its pathologic features and significance are unclear. In this study, the tissue VEGF expression levels and its gene transcriptional status, as well as circulating VEGF levels, were investigated in patients with lung disease. Methods: VEGF protein and mRNA expression levels in 38 lung tissue samples were analyzed by immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR), respectively. Circulating VEGF levels were detected quantitatively by an enzyme linked immuno-sorbent assay. Results: The level of VEGF expression was significantly higher in lung cancer tissue than in the corresponding paracancerous or non-cancerous tissues. The average level of VEGF-positive staining was 76% in tissue samples from NSCLC patients; the levels were 89% in tissue samples from stage III patients and 92% in stage IV patients. High VEGF expression was also evident in cases with lymph node metastasis (84%), distant metastasis (90%), and lower differentiation degree (89%). VEGF mRNA in cancerous tissues was represented predominantly by the VEGF121 and VEGF165 isoforms. Circulating VEGF levels were significantly higher in NSCLC patients [(840 ± 324) pg/mL] than in patients with benign lung diseases [(308 ± 96) pg/mL] or in healthy individuals serving as controls [(252 ± 108) pg/mL]. Conclusion: The over-expression of lung VEGF and its gene transcription status should be useful molecular indicators for NSCLC diagnosis.
View Full Text   Download reader  HTML全文
Close